학술논문

Photodynamic Therapy-Induced Acute Exudative Maculopathy (PAEM): Prevalence, Impact and Management Strategies
Document Type
Academic Journal
Source
Clinical Ophthalmology. September 30, 2022, Vol. 16, p3145, 10 p.
Subject
Company business management
Verteporfin
Strategic planning (Business)
Cancer -- Photochemotherapy
Vascular endothelial growth factor
Photochemotherapy
Language
English
ISSN
1177-5483
Abstract
Photodynamic therapy (PDT) has a niche role in treating various choroidal pathologies. PDT-induced acute exudative maculopathy (PAEM) is an uncommon complication of PDT that results in exudative retinal detachment and mild to severe decrease in vision. Successful management strategies include observation, local or systemic corticosteroids, and intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections. Most cases return to visual acuity near baseline. This review summarizes what is known about PAEM to date including etiology, prevalence, management strategies, and outcomes. We conclude that management of PAEM must take into consideration various patient-specific factors. Treatment with corticosteroids or anti-VEGF agents may expedite time to recovery, though lack of randomized controlled trials preclude firm conclusions regarding a standardized approach to managing this complication of PDT. Keywords: photodynamic therapy, exudative maculopathy, serous detachment
Introduction Photodynamic therapy (PDT) is a treatment used in ophthalmology for various choroidal pathologies. Selected patients receive an intravenous infusion of a photosensitizing porphyrin-based agent and then target lesions are [...]